Related Experiment Video

Updated: Sep 2, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Ray of light for treatment of head and neck cancer

K Morris

    The Lancet. Oncology
    |March 22, 2002
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
    08:25

    Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

    Published on: April 11, 2018

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    Related Experiment Videos

    Last Updated: Sep 2, 2026

    Stereotactic Radiosurgery for Gynecologic Cancer
    10:35

    Stereotactic Radiosurgery for Gynecologic Cancer

    Published on: April 17, 2012

    Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
    08:25

    Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

    Published on: April 11, 2018

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    Related Concept Videos

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

    Articles linked to this work by shared authors, journal, and citation graph.

    Documenting interventions delivered by the Disability Liaison Officer Program to achieve equity in healthcare.

    Disability and rehabilitation·2025

    Development and characterisation of mgTHP-1, a novel in vitro model for neural macrophages with microglial characteristics.

    Neurological research·2023

    Microbial interactions with phosphorus containing glasses representative of vitrified radioactive waste.

    Journal of hazardous materials·2023

    Early but reversible haemostatic changes in a-symptomatic females expressing COVID-19 antibodies.

    Thrombosis research·2022

    The treatment effect of rivaroxaban on clot characteristics in patients who present acutely with first time deep vein thrombosis.

    Clinical hemorheology and microcirculation·2021

    An evaluation of the current mentorship/preceptorship practices for newly qualified radiographers in Northern Ireland.

    Radiography (London, England : 1995)·2020

    Invasive interval breast cancer rates after digital breast tomosynthesis plus synthesised mammography versus digital mammography screening (TOSYMA): 24-month follow-up of the multicentre, open-label, randomised, controlled, superiority trial.

    The Lancet. Oncology·2026

    Neoadjuvant niraparib monotherapy for unresectable, homologous recombination deficiency-positive, high-grade serous ovarian cancer (NANT): a multicentre, single-arm, phase 2 trial.

    The Lancet. Oncology·2026

    Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer.

    The Lancet. Oncology·2026

    Cancer and the microbiome: from association to intervention.

    The Lancet. Oncology·2026

    Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer (CHN HYPOPMRT): 10-year outcomes from a randomised, non-inferiority, open-label, phase 3 trial.

    The Lancet. Oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us